Vor Biopharma
VOR
VOR
54 hedge funds and large institutions have $332M invested in Vor Biopharma in 2025 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 19 increasing their positions, 2 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
81% more capital invested
Capital invested by funds: $183M → $332M (+$148M)
46% more funds holding
Funds holding: 37 → 54 (+17)
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
Holders
54
Holding in Top 10
4
Calls
$16.2M
Puts
$5.93M
Top Buyers
| 1 | +$63.7M | |
| 2 | +$60.3M | |
| 3 | +$47.4M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$42.6M |
| 5 |
PBA
Paradigm Biocapital Advisors
New York
|
+$32.6M |
Top Sellers
| 1 | -$5.37M | |
| 2 | -$2.44M | |
| 3 | -$1.33M | |
| 4 |
PCMH
Polymer Capital Management (HK)
Hong Kong
|
-$1.04M |
| 5 |
Renaissance Technologies
New York
|
-$711K |
